Folgen
Dirk A Lamprecht
Dirk A Lamprecht
Johnson & Johnson Innovative Medicines
Bestätigte E-Mail-Adresse bei its.jnj.com
Titel
Zitiert von
Zitiert von
Jahr
Turning the respiratory flexibility of Mycobacterium tuberculosis against itself
DA Lamprecht, PM Finin, MA Rahman, BM Cumming, SL Russell, ...
Nature communications 7 (1), 12393, 2016
2292016
Ergothioneine maintains redox and bioenergetic homeostasis essential for drug susceptibility and virulence of Mycobacterium tuberculosis
V Saini, BM Cumming, L Guidry, DA Lamprecht, JH Adamson, VP Reddy, ...
Cell reports 14 (3), 572-585, 2016
1492016
Hydrogen sulfide stimulates Mycobacterium tuberculosis respiration, growth and pathogenesis
V Saini, KC Chinta, VP Reddy, JN Glasgow, A Stein, DA Lamprecht, ...
Nature communications 11 (1), 557, 2020
952020
Compromised metabolic reprogramming is an early indicator of CD8+ T cell dysfunction during chronic Mycobacterium tuberculosis infection
SL Russell, DA Lamprecht, T Mandizvo, TT Jones, V Naidoo, KW Addicott, ...
Cell reports 29 (11), 3564-3579. e5, 2019
792019
2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium tuberculosis: Structure–Activity Relationships, Mechanism of Action …
D Murugesan, PC Ray, T Bayliss, GA Prosser, JR Harrison, K Green, ...
ACS infectious diseases 4 (6), 954-969, 2018
702018
Arylvinylpiperazine amides, a new class of potent inhibitors targeting QcrB of Mycobacterium tuberculosis
CS Foo, A Lupien, M Kienle, A Vocat, A Benjak, R Sommer, ...
MBio 9 (5), 10.1128/mbio. 01276-18, 2018
652018
Susceptibility of Mycobacterium tuberculosis Cytochrome bd Oxidase Mutants to Compounds Targeting the Terminal Respiratory Oxidase, Cytochrome c
A Moosa, DA Lamprecht, K Arora, CE Barry III, HIM Boshoff, TR Ioerger, ...
Antimicrobial agents and chemotherapy 61 (10), 10.1128/aac. 01338-17, 2017
652017
Mycobacterium tuberculosis arrests host cycle at the G1/S transition to establish long term infection
BM Cumming, MA Rahman, DA Lamprecht, KH Rohde, V Saini, ...
PLoS pathogens 13 (5), e1006389, 2017
482017
New 2-Ethylthio-4-methylaminoquinazoline derivatives inhibiting two subunits of cytochrome bc1 in Mycobacterium tuberculosis
A Lupien, CSY Foo, S Savina, A Vocat, J Piton, N Monakhova, A Benjak, ...
PLoS pathogens 16 (1), e1008270, 2020
472020
The physiology and genetics of oxidative stress in mycobacteria
BM Cumming, DA Lamprecht, RM Wells, V Saini, JH Mazorodze, ...
Molecular Genetics of Mycobacteria, 297-322, 2014
472014
Bedaquiline reprograms central metabolism to reveal glycolytic vulnerability in Mycobacterium tuberculosis
JS Mackenzie, DA Lamprecht, R Asmal, JH Adamson, K Borah, ...
Nature communications 11 (1), 6092, 2020
432020
Turning the respiratory flexibility of Mycobacterium tuberculosis against itself. Nat Commun 7: 12393
DA Lamprecht, PM Finin, MA Rahman, BM Cumming, SL Russell, ...
412016
Accessible and distinct decoquinate derivatives active against Mycobacterium tuberculosis and apicomplexan parasites
RM Beteck, R Seldon, D Coertzen, ME van der Watt, J Reader, ...
Communications Chemistry 1 (1), 62, 2018
322018
Ergothioneine maintains redox and bioenergetic homeostasis essential for drug susceptibility and virulence of Mycobacterium tuberculosis. Cell Rep 14: 572–585
V Saini, BM Cumming, L Guidry, DA Lamprecht, JH Adamson, VP Reddy, ...
192016
Mycobacterium tuberculosis H2S Functions as a Sink to Modulate Central Metabolism, Bioenergetics, and Drug Susceptibility
TTR Kunota, MA Rahman, BE Truebody, JS Mackenzie, V Saini, ...
Antioxidants 10 (8), 1285, 2021
182021
An enzyme-initiated Smiles rearrangement enables the development of an assay of MshB, the GlcNAc-Ins deacetylase of mycothiol biosynthesis
DA Lamprecht, NO Muneri, H Eastwood, KJ Naidoo, E Strauss, A Jardine
Organic & Biomolecular Chemistry 10 (27), 5278-5288, 2012
112012
667 Adamson JH, Steyn AJ. 2016
DA Lamprecht, PM Finin, MA Rahman, BM Cumming, SL Russell, ...
Turning the respiratory flexibility of Mycobacterium 668, 0
4
Correction: Mycobacterium tuberculosis arrests host cycle at the G1/S transition to establish long term infection
BM Cumming, MA Rahman, DA Lamprecht, KH Rohde, V Saini, ...
Plos Pathogens 13 (7), e1006490, 2017
32017
A high-throughput target-based screening approach for the identification and assessment of Mycobacterium tuberculosis mycothione reductase inhibitors
N Smiejkowska, L Oorts, K Van Calster, L De Vooght, R Geens, ...
Microbiology Spectrum 12 (3), e03723-23, 2024
22024
Imidazopyridine amides and related compounds for use in the treatment of bacterial infections
JM Bartolomé-nebreda, ML Martín-martín, DA Lamprecht, BHT Stoops, ...
US Patent App. 18/705,114, 2025
12025
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20